Risk Factors for Deep-Vein Thrombosis and Pulmonary Thromboembolism in Benign Ovarian Tumor

被引:5
|
作者
Shiota, Mitsuru [1 ]
Kotani, Yasushi [1 ]
Umemoto, Masahiko [1 ]
Tobiume, Takako [1 ]
Tsuritani, Mitsuhiro [1 ]
Shimaoka, Masao [1 ]
Hoshiai, Hiroshi [1 ]
机构
[1] Kinki Univ, Fac Med, Dept Obstet & Gynecol, Osaka 5898511, Japan
来源
关键词
d-dimer; deep-vein thrombosis; ovarian tumor; postoperative complication; pulmonary thromboembolism; VENOUS THROMBOEMBOLISM; OUTCOMES;
D O I
10.1620/tjem.225.1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pulmonary thromboembolism (PE) is a serious postoperative complication. Reported rates of PE following gynecologic surgery are between 0.3% and 0.8%, with deep-vein thrombosis (DVT) as the major cause (via seeding of the lungs). Benign ovarian tumors are treated principally by surgery. Possible risk factors for DVT and PE in patients with benign ovarian tumors include tumor size, patient age, and obesity. To date, however, there has been no report addressing the association of these risk factors in patients with benign ovarian tumors. This study offers a retrospective analysis of the incident of preoperative DVT by age, tumor size, and BMI in patients undergoing surgery for benign ovarian tumors. A total of 843 Japanese patients with a preoperative diagnosis of benign ovarian tumor who underwent tumorectomy or adnexectomy at our institution between July 2003 and December 2010 were enrolled. The incidence of preoperative DVT was monitored and statistically stratified by age (< 50 years and >= 50 years), largest tumor diameter (< 10 cm and >= 10 cm), and BMI (< 25 and >= 25). The result indicates that tumor diameter of >= 10 cm is not a risk factor for preoperative DVT in patients with benign ovarian tumor. On the other hand, age >= 50 years and BMI > 25 are independent risk factors for preoperative DVT in Japan. The patients with each risk factor should be treated with preoperative, intraoperative, and postoperative precautions against development of PE.
引用
收藏
页码:1 / 3
页数:3
相关论文
共 50 条
  • [31] Hyperhomocysteinemia as a risk factor for deep-vein thrombosis
    denHeijer, M
    Koster, T
    Blom, HJ
    Bos, GMJ
    Briet, E
    Reitsma, PH
    Vandenbroucke, JP
    Rosendaal, FR
    NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (12): : 759 - 762
  • [32] Hypercholesterolemia as a risk factor for deep-vein thrombosis
    Kawasaki, T
    Kambayashi, J
    Ariyoshi, H
    Sakon, M
    Suehisa, E
    Monden, M
    THROMBOSIS RESEARCH, 1997, 88 (01) : 67 - 73
  • [33] Hyperhomocysteinemia as a risk factor for deep-vein thrombosis
    Cattaneo, M
    Martinelli, I
    Mannucci, PM
    NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (13): : 974 - 975
  • [34] Deep-vein thrombosis
    Malhotra, P
    LANCET, 1999, 353 (9165): : 1708 - 1708
  • [35] DEEP-VEIN THROMBOSIS
    CREUTZIG, A
    ZEITSCHRIFT FUR KARDIOLOGIE, 1993, 82 : 41 - 47
  • [36] DEEP-VEIN THROMBOSIS
    PFLUG, JJ
    PRACTITIONER, 1976, 217 (1301) : 686 - &
  • [37] DEEP-VEIN THROMBOSIS
    UDELL, JL
    NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (21): : 1447 - 1447
  • [38] DEEP-VEIN THROMBOSIS
    CONNOLLY, AAP
    BRITISH MEDICAL JOURNAL, 1988, 297 (6643): : 292 - 292
  • [39] Factor V Leiden paradox: risk of deep-vein thrombosis but not of pulmonary embolism
    Bounameaux, H
    LANCET, 2000, 356 (9225): : 182 - 183
  • [40] DEEP-VEIN THROMBOSIS AND ASYMPTOMATIC PULMONARY-EMBOLISM
    MONREAL, M
    LAFOZ, E
    FOZ, M
    ANGLES, AM
    MONASTERIO, J
    THROMBOSIS RESEARCH, 1986, : 80 - 80